Mind Medicine (MindMed) Inc. (MNMD)
Largest Insider Buys in Sector
MNMD Stock Price History Chart
MNMD Stock Performance
About Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of …
Insider Activity of Mind Medicine (MindMed) Inc.
Over the last 12 months, insiders at Mind Medicine (MindMed) Inc. have bought $45,070 and sold $804,416 worth of Mind Medicine (MindMed) Inc. stock.
On average, over the past 5 years, insiders at Mind Medicine (MindMed) Inc. have bought $45,070 and sold $449,102 worth of stock each year.
Highest buying activity among insiders over the last 12 months: GRYSKA DAVID W (director) — $77,710. Barrow Robert (Chief Executive Officer) — $6,215.
The last purchase of 2,500 shares for transaction amount of $17,925 was made by GRYSKA DAVID W (director) on 2024‑12‑05.
List of Insider Buy and Sell Transactions, Mind Medicine (MindMed) Inc.
| 2024-12-05 | director | 2,500 0.0035% | $7.17 | $17,925 | +2.53% | |||
| 2024-09-25 | Sale | Chief Executive Officer | 19,771 0.0197% | $5.98 | $118,231 | +13.26% | ||
| 2024-09-25 | Sale | Chief Medical Officer | 6,871 0.0069% | $5.98 | $41,089 | +13.26% | ||
| 2024-09-25 | Sale | Chief Legal Officer | 4,430 0.0044% | $5.98 | $26,491 | +13.26% | ||
| 2024-09-25 | Sale | Chief Accounting Officer | 2,352 0.0023% | $5.98 | $14,065 | +13.26% | ||
| 2024-08-23 | director | 3,500 0.0035% | $5.98 | $20,930 | +4.82% | |||
| 2024-08-20 | Chief Executive Officer | 500 0.0005% | $6.12 | $3,060 | +2.19% | |||
| 2024-08-19 | Chief Executive Officer | 500 0.0005% | $6.31 | $3,155 | -0.94% | |||
| 2024-06-25 | Sale | Chief Executive Officer | 15,659 0.0189% | $7.22 | $113,058 | -3.39% | ||
| 2024-06-25 | Sale | Chief Medical Officer | 6,925 0.0083% | $7.22 | $49,999 | -3.39% | ||
| 2024-06-25 | Sale | Chief Legal Officer | 17,854 0.0215% | $7.22 | $128,906 | -3.39% | ||
| 2024-03-25 | Sale | Chief Executive Officer | 16,519 0.0262% | $9.50 | $156,931 | -28.76% | ||
| 2024-03-25 | Sale | Chief Medical Officer | 6,578 0.0104% | $9.50 | $62,491 | -28.76% | ||
| 2023-12-26 | Sale | Chief Executive Officer | 13,237 0.008% | $3.63 | $48,050 | +84.75% | ||
| 2023-12-26 | Sale | Chief Medical Officer | 6,774 0.0041% | $3.63 | $24,590 | +84.75% | ||
| 2023-12-26 | Sale | Chief Financial Officer | 5,652 0.0034% | $3.63 | $20,517 | +84.75% | ||
| 2023-09-25 | Sale | Chief Executive Officer | 13,499 0.0081% | $3.58 | $48,274 | +69.92% | ||
| 2023-09-25 | Sale | Chief Medical Officer | 6,918 0.0041% | $3.57 | $24,730 | +69.92% | ||
| 2023-09-25 | Sale | Chief Financial Officer | 5,762 0.0034% | $3.58 | $20,609 | +69.92% | ||
| 2023-08-25 | Sale | Chief Financial Officer | 20,000 0.0127% | $3.80 | $76,000 | +37.11% |